Table 3.
Comparison of model fit characteristics overall and stratified by BMI category.
Modela | Overall | Lean | Overweight | Obese | ||||
---|---|---|---|---|---|---|---|---|
AIC* | AUC | AIC* | AUC | AIC* | AUC | AIC* | AUC | |
Without clinical covariates | ||||||||
MH | 20,240 | 0.58 | 4343 | 0.55 | 5846 | 0.56 | 7038 | 0.54 |
MH + LDL-P | 20,222 | 0.59 | 4343 | 0.55 | 5837 | 0.57 | 7032 | 0.55 |
MH + LP-IR | 20,179 | 0.61 | 4332 | 0.59 | 5831 | 0.60 | 7006 | 0.59 |
MH + GlycA | 20,162 | 0.63 | 4315 | 0.62 | 5821 | 0.63 | 7016 | 0.60 |
MH + HMSP | 20,051 | 0.64 | 4300 | 0.63 | 5782 | 0.65 | 6952 | 0.62 |
MH + BCAA | 20,232 | 0.61 | 4344 | 0.57 | 5846 | 0.61 | 7032 | 0.59 |
MH + SCDA | 20,155 | 0.62 | 4329 | 0.57 | 5807 | 0.62 | 7010 | 0.59 |
MH + all plasma biomarkers | 19,919 | 0.69 | 4269 | 0.68 | 5745 | 0.69 | 6907 | 0.67 |
With clinical covariates* | ||||||||
MH + clinical covariates | 19,676 | 0.75 | 4241 | 0.71 | 5645 | 0.76 | 6780 | 0.75 |
MH + LDL-P + clinical covariates | 19,675 | 0.75 | 4243 | 0.72 | 5643 | 0.76 | 6782 | 0.75 |
MH + LP-IR + clinical covariates | 19,660 | 0.75 | 4239 | 0.72 | 5644 | 0.76 | 6771 | 0.75 |
MH + GlycA + clinical covariates | 19,599 | 0.76 | 4210 | 0.74 | 5619 | 0.78 | 6761 | 0.76 |
MH + HMSP + clinical covariates | 19,561 | 0.76 | 4207 | 0.73 | 5613 | 0.77 | 6728 | 0.76 |
MH + BCAA + clinical covariates | 19,674 | 0.75 | 4241 | 0.72 | 5647 | 0.76 | 6781 | 0.75 |
MH + SCDA + clinical covariates | 19,651 | 0.75 | 4236 | 0.72 | 5630 | 0.76 | 6781 | 0.75 |
MH + all plasma biomarkers + clinical covariates | 19,482 | 0.77 | 4180 | 0.75 | 5588 | 0.78 | 6711 | 0.77 |
*AIC analyses were restricted to individuals who had data needed for all models of traditionally defined MH and for all biomarkers (n = 3222).
Clinical covariates include: age, sex, race, LVEF, CAD, family history of CAD, smoking, LDL-C, and creatinine.